Category: Health & Medicines > Medicines > Insulin Pen
Country/Region: South Korea State/Province: Gyeonggi
Main Products: Insulin Pen Needle, Needle
Business Type: Exporter, Buying House
Year Established: 2001
Employees: 101 - 200 People
Plant Area: 30,000-50,000 square meters
Main Markets: South America 10% Africa 12% Eastern Asia 9% Domestic Market 8% North America 10% Eastern Europe 11% Southern Europe 8% Mid East 12% Northern Europe 12% Oceania 8%
Trade Capacity: FOB, EXW, DDP
Contract Manufacturing: OEM Service Offered
Nearest Port: Seoul
Annual Revenue: US$5 Million - US$10 Million
Total Revenue: US$1 Million - US$2.5 Million
Export Revenue: Below US$1 Million
Annual Output: US$2.5 Million - US$5 Million
Registered Capital: Below US$1 Million
Export Percentage: 71% - 80%
Payment Modes: USD, EUR, CNY
Lead Time: 10 days
Import/Export Mode: Using an agent